Abstract
Over the past decades, the possibility of using non-invasive brain stimulation (NIBS) to treat mental disorders received considerable attention. To date, no recommendation is available for anxiety disorders, suggesting that evidence is still limited. Here, we systematically revised the existing literature, and quantitively analyzed the effectiveness of transcranial magnetic stimulation and transcranial direct current stimulation in anxiety disorders treatment.
Following PRISMA guidelines, three electronic databases were screened to the end of February 2020 to select English-written peer-reviewed articles, including a clinical anxiety sample, a NIBS technique, and a control condition. Overall, ten papers met the inclusion criteria.
TheHedge g for scores at the specific and generic anxiety questionnaires before and after the treatment was computed as effect size and analyzed in two independent random-effects meta-analyses. Moreover, considering the well-known comorbidity between anxiety and depression, a third meta-analysis was run, analyzing depression scores’ outcomes. Albeit preliminary, our findings highlighted that real stimulation significantly reduced anxiety and depression scores compared to the control condition, suggesting that NIBS can alleviate clinical symptoms.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
AV was supported in part by a 2019 NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This is a meta-analysis, so we are not reporting patients data.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
AV was supported in part by a 2019 NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation.
Data Availability
Data are available upon reasonable request
